Gökhan Yıldız

6PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Neonatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 18, 2026
NHSL3 knockout modulates sorafenib response, growth, and motility in hepatocellular carcinoma cell models.

|Apr 14, 2026
Loss of LLGL1 Elevates EGFR/RAS/MAPK Signaling and Remodels EMT Markers in Huh-7 Hepatocellular Carcinoma Cells.

Gökhan Yıldız, Soner Karabulut, Tuba Dincer

|Feb 27, 2026
LZTR1 Loss Reduces Vimentin Expression and Motility in Hep3B Hepatocellular Carcinoma Cells.

Gökhan Yıldız, Soner Karabulut, Umit Uzun

|Dec 30, 2025
Modulation of Oxidative and ER Stress Pathways by the ADAM17 Inhibitor GW280264X in LPS-Induced Acute Liver Injury.

Merve Huner Yigit, Oguzhan Okcu, Mehtap Atak

|Mar 13, 2021
A novel homozygous RIPK4 variant in a family with severe Bartsocas-Papas syndrome.

Tuba Dinçer, Evren Gümüş, Bayram Toraman

|Mar 06, 2021
TAp73β Can Promote Hepatocellular Carcinoma Dedifferentiation.

Evin Iscan, Umut Ekin, Gokhan Yildiz

Pageof 1

Frequent Collaborators

3 joint publications

Tuba Dinçer

3 joint publications

Soner Karabulut

1 joint publications

Umur Keles

1 joint publications

Aslı Suner